Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,910.00    -24.00 (-0.49%)
Bid:
4,910.00
Ask:
4,912.00
Spread: 2.00 (0.041%)
Market Cap: £17.90b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director/PDMR Shareholding

23 Dec 2025 14:45

RNS Number : 7108M
Coca-Cola HBC AG
23 December 2025
 

FOR IMMEDIATE RELEASE

23 December 2025

 

Coca-Cola HBC AG (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs')

The Company notifies that the following PDMR has been granted at nil cost performance shares of CHF 6.70 each ("Shares") in the Company on 10 November 2025 through her participation in the Stock Option and Performance Share Award Plan ("PSP"). The performance shares will vest as described below subject to achievement of performance conditions.

 PDMR

Number of Shares granted under the PSP

Share price

PANAGIOTA KALOGERAKI

5,898.31

GBP 35.90

 

The Notification of Dealing Forms for each PDMR can be found below.

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

PANAGIOTA KALOGERAKI

2

 

Reason for the notification

a)

 

Position/status

 

CHIEF OPERATING OFFICER

b)

 

Initial notification /Amendment

 

INITIAL NOTIFICATION

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

COCA-COLA HBC AG

b)

 

LEI

 

549300EFP3TNG7JGVE49

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

SHARES

 

 

CH0198251305

b)

 

Nature of the transaction

 

 

GRANTING OF PERFORMANCE SHARES AT NIL COST WHICH WILL VEST IN NOVEMBER 2028 SUBJECT TO ACHIEVEMENT OF PERFORMANCE CONDITIONS OF THE 2025-2027 PERFORMANCE SHARE PLAN.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

35.90 GBP

5,898.31

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Price

Volume

Total

35.90 GBP

5,898.31

211,749.329 GBP

e)

 

Date of the transaction

 

2025-11-10

f)

 

Place of the transaction

 

OUTSIDE A TRADING VENUE

 

This notification is made in accordance with the requirements of the UK Market Abuse Regulation and EU Market Abuse Regulation. The grant of the Shares was deferred for administrative reasons and to ensure compliance with the Market Abuse Regulation while the recipient was in possession of inside information.

For further information please contact:

Jan Gustavsson

General Counsel and Company Secretary

+41 (0) 41 726 01 10

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPKNBDQBDDCBB
Date   Source Headline
22nd Feb 20233:43 pmRNSDirector/PDMR Shareholding
20th Feb 20232:46 pmRNSDirector/PDMR Shareholding
20th Feb 20232:13 pmRNSDirector/PDMR Shareholding
16th Feb 202311:28 amRNSDirector/PDMR Shareholding
14th Feb 20237:00 amRNSStrong execution drives another year of growth
1st Feb 20231:50 pmRNSIssue of equity and total voting rights
18th Jan 20232:47 pmRNSDirector/PDMR Shareholding
17th Jan 20239:34 amRNSNotice of Results
5th Jan 202310:14 amRNSAthens Exchange trading date of ordinary shares
4th Jan 20233:02 pmRNSDirector/PDMR Shareholding
20th Dec 202210:16 amRNSPost 2022 AGM Shareholder Engagement
19th Dec 20223:03 pmRNSDirector/PDMR Shareholding
1st Dec 20227:44 amRNSIssue of equity and total voting rights
18th Nov 20223:13 pmRNSDirector/PDMR Shareholding
17th Nov 20228:41 amRNSDirector/PDMR Shareholding
16th Nov 20225:06 pmRNSDirector/PDMR Shareholding
14th Nov 20222:36 pmRNSDirector/PDMR Shareholding
11th Nov 20221:32 pmRNSDirector/PDMR Shareholding
11th Nov 20221:24 pmRNSDirector/PDMR Shareholding
8th Nov 20227:00 amRNSContinued positive momentum
1st Nov 20222:50 pmRNSBlock listing Interim Review
18th Oct 20223:05 pmRNSDirector/PDMR Shareholding
13th Oct 202210:40 amRNSNotice of Results
3rd Oct 202210:03 amRNSIssue of equity and total voting rights
28th Sep 20221:28 pmRNSDirector/PDMR Shareholding
21st Sep 20225:07 pmRNSIssue of Debt
20th Sep 202211:51 amRNSDirector/PDMR Shareholding
16th Sep 202212:32 pmRNS2022 Performance Share Plan Awards
15th Sep 20225:21 pmRNSIssue of Debt
15th Sep 20222:44 pmRNSHolding(s) in Company
15th Sep 20228:49 amRNSIssue of Debt
13th Sep 202212:38 pmRNSDirector/PDMR Shareholding
7th Sep 202212:05 pmRNSHolding(s) in Company
6th Sep 20222:03 pmRNSPublication of a Prospectus
30th Aug 20229:14 amRNSHolding(s) in Company
25th Aug 20229:01 amRNSHolding(s) in Company
23rd Aug 20221:45 pmRNSHolding(s) in Company
23rd Aug 202211:06 amRNSHolding(s) in Company
18th Aug 20223:43 pmRNSHolding(s) in Company
18th Aug 202212:05 pmRNSHolding(s) in Company
18th Aug 202211:24 amRNSDirector/PDMR Shareholding
11th Aug 202212:40 pmRNSHolding(s) in Company
11th Aug 20227:00 amRNSStrong volumes, revenue, EBIT; investing in growth
9th Aug 20221:45 pmRNSDirector/PDMR Shareholding
9th Aug 20227:00 amRNSCCH agrees to acquire Three Cents
19th Jul 202212:53 pmRNSDirector/PDMR Shareholding
19th Jul 202210:48 amRNSNotice of Results
22nd Jun 202210:45 amRNSHolding(s) in Company
21st Jun 20224:28 pmRNSResult of AGM
20th Jun 20222:38 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.